Campaigners are expressing concerns that babies like Jesy Nelson’s twins, who are affected by a severe muscle wasting disease, are being overlooked by the government. The former member of the music group Little Mix, along with other parents of infants with spinal muscular atrophy (SMA), recently participated in a parliamentary debate urging universal testing for the condition in newborns. NHS treatments have proven to be highly effective if administered promptly after birth to prevent irreversible nerve damage in the initial weeks of life.
During a recent government update by Health Minister Sharon Hodges, it was revealed that an NHS pilot program is still hesitant to extend testing to more than 160,000 newborns annually, citing the need to ensure that screening would bring more benefits than harm. This decision has raised concerns among campaigners, who feel that the resignation of the previous health secretary, Wes Streeting, has led to a backtrack on the government’s commitment regarding SMA screening expansion.
According to SMA UK, since Wes Streeting’s pledge to explore England-wide testing, approximately 12 babies might have been born with SMA every 12 weeks without being screened, resulting in delayed diagnoses and complex healthcare requirements. Giles Lomax, CEO of SMA UK, emphasized the urgency of the situation, criticizing the government for excluding these vulnerable babies and emphasizing the need for swift action.
Former Health Secretary Wes Streeting had accelerated the start date of an NHS pilot program for newborn screening after interactions with Jesy Nelson, moving it up to October this year from the original date of January 2027. However, the current plans still leave over 160,000 newborns untested annually as part of a control group.
The delay in decision-making on nationwide SMA screening has sparked a wave of support from numerous Members of Parliament who are advocating for an expansion of screening services. Health Minister Sharon Hodgson acknowledged the frustration felt by families and advocates, emphasizing the meticulous evaluation required to ensure that screening initiatives are both beneficial and safe for newborns.
International evidence suggests that screening for SMA at birth can prevent fatalities, long-term disabilities, and ultimately reduce healthcare costs. Despite the promising outcomes seen in other countries, the UK government is facing criticism for its slow progress in implementing a national screening program for SMA.
Jesy Nelson, in collaboration with the Mirror, has been campaigning for universal SMA screening for newborns. Her personal experience with delayed diagnosis for her own twins has fueled her advocacy for timely screening to prevent irreversible health consequences. The Department of Health and Social Care has acknowledged the powerful arguments put forth by campaigners and is currently planning a large-scale trial across the NHS to gather data supporting a national screening program.
Efforts are underway to ensure that more treatments are available for SMA patients, aiming for improved health outcomes and a better quality of life for affected children. The government aims to expedite the screening process, with the hope of not only saving lives but also enabling children with SMA to thrive.